{"id":"NCT00102804","sponsor":"Eli Lilly and Company","briefTitle":"Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC)","officialTitle":"A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Immediately Following Induction Treatment for Advanced Non-Small Cell Lung Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-03","primaryCompletion":"2007-08","completion":"2013-12","firstPosted":"2005-02-02","resultsPosted":"2014-12-29","lastUpdate":"2014-12-29"},"enrollment":663,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Non-Small Cell Lung Cancer"],"interventions":[{"type":"DRUG","name":"Pemetrexed","otherNames":["LY231514","Alimta"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"OTHER","name":"Best Supportive Care","otherNames":[]}],"arms":[{"label":"Pemetrexed and Best Supportive Care","type":"EXPERIMENTAL"},{"label":"Placebo and Best Supportive Care","type":"PLACEBO_COMPARATOR"}],"summary":"This study is a randomized Phase 3, double-blind study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care in NSCLC. Participants must have received 1 of 6 induction regimens for 4 cycles and did not have progressive disease prior to randomization (enrollment) into this trial.","primaryOutcome":{"measure":"Progression-Free Survival (PFS) Time","timeFrame":"Randomization to measured PD or death from any cause (up to 41 months)","effectByArm":[{"arm":"Pemetrexed and BSC","deltaMin":4.27,"sd":null},{"arm":"Placebo and BSC","deltaMin":2.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":73,"countries":["United States","Australia","Austria","Brazil","Bulgaria","China","Croatia","Czechia","Germany","Greece","Hungary","India","Italy","Netherlands","Poland","Romania","South Korea","Spain","Taiwan","Turkey (TÃ¼rkiye)"]},"refs":{"pmids":["22336221","22266043","19767093"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":83,"n":438},"commonTop":["Fatigue","Anorexia","Cough","Dyspnoea","Nausea"]}}